Jake is Vice President and Head of Business Development at Averna Therapeutics, bringing over 15 years of biopharma experience and more than a decade in corporate and business development. He began his career as an investment banker and strategy consultant at Leerink Partners and later held senior roles at Orna Therapeutics, where he contributed to high-profile collaborations with Merck ($3.6B) and Vertex ($4B). He has also held corporate and business development roles of increasing responsibility at publicly traded companies, including Pfizer, Biogen, and Teleflex.
He holds a BA in economics from New York University.